4D Molecular Therapeutics, Inc. — All Filings
385 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
144/A
3
3/A
4
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
EFFECT
FWP
POS AM
POSASR
RW
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
S-8 POS
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 424B5 | 424B5 | 0001193125-23-138372 | May 8, 2023 | — |
| 4 | — | 0001140361-23-023022 | May 4, 2023 | May 2, 2023 |
| S-8 POS | S-8 POS | 0001193125-23-134747 | May 4, 2023 | — |
| 424B5 | 424B5 | 0001193125-23-135977 | May 4, 2023 | — |
| 4 | — | 0001140361-23-020316 | Apr 25, 2023 | Apr 21, 2023 |
| 4 | — | 0001140361-23-020315 | Apr 25, 2023 | Apr 21, 2023 |
| 144 | — | 0001968582-23-000019 | Apr 21, 2023 | — |
| 144 | — | 0001950047-23-000207 | Apr 21, 2023 | — |
| DEFA14A | DEFA14A | 0001193125-23-098528 | Apr 12, 2023 | — |
| DEF 14A | DEF 14A | 0001193125-23-098511 | Apr 12, 2023 | May 23, 2023 |
| 3 | FORM 3 | 0001567619-23-005526 | Apr 5, 2023 | Mar 24, 2023 |
| S-8 | S-8 | 0001193125-23-071361 | Mar 15, 2023 | — |
| 8-K | 8-K | 0000950170-23-008146 | Mar 15, 2023 | — |
| 10-K | 10-K | 0000950170-23-008142 | Mar 15, 2023 | Dec 31, 2022 |
| 4 | FORM 4 | 0001567619-23-004430 | Mar 3, 2023 | Mar 1, 2023 |
| 4 | FORM 4 | 0001567619-23-003706 | Feb 23, 2023 | Feb 21, 2023 |
| 4 | FORM 4 | 0001567619-23-003007 | Feb 14, 2023 | Feb 10, 2023 |
| SC 13G/A | — | 0001172661-23-000826 | Feb 14, 2023 | — |
| 4 | FORM 4 | 0001567619-23-003006 | Feb 14, 2023 | Feb 10, 2023 |
| 4 | FORM 4 | 0001567619-23-003008 | Feb 14, 2023 | Feb 10, 2023 |
| 4 | FORM 4 | 0001567619-23-003009 | Feb 14, 2023 | Feb 10, 2023 |
| SC 13G/A | SC 13G/A | 0001193125-23-028417 | Feb 8, 2023 | — |
| 8-K | 8-K | 0001193125-23-023004 | Feb 3, 2023 | Feb 2, 2023 |
| SC 13G/A | — | 0001306550-23-005186 | Jan 31, 2023 | — |
| 8-K | 8-K | 0001193125-23-016298 | Jan 26, 2023 | Jan 9, 2023 |
| 4 | FORM 4 | 0001567619-23-001163 | Jan 23, 2023 | Jan 19, 2023 |
| 4 | FORM 4 | 0001567619-22-021958 | Dec 22, 2022 | Dec 21, 2022 |
| 4 | FORM 4 | 0001567619-22-021815 | Dec 19, 2022 | Dec 15, 2022 |
| 4 | FORM 4 | 0001567619-22-021291 | Dec 5, 2022 | Dec 1, 2022 |
| 8-K | 8-K | 0000950170-22-023839 | Nov 9, 2022 | — |
| 10-Q | 10-Q | 0000950170-22-023185 | Nov 8, 2022 | Sep 30, 2022 |
| 4 | FORM 4 | 0001567619-22-017850 | Sep 27, 2022 | Sep 23, 2022 |
| 4 | FORM 4 | 0001567619-22-017847 | Sep 27, 2022 | Sep 23, 2022 |
| 3 | FORM 3 | 0001567619-22-017845 | Sep 27, 2022 | Sep 23, 2022 |
| 8-K | 8-K | 0001193125-22-252180 | Sep 27, 2022 | Sep 23, 2022 |
| 4 | FORM 4 | 0001567619-22-017102 | Sep 6, 2022 | Sep 1, 2022 |
| 4 | FORM 4 | 0001567619-22-017101 | Sep 6, 2022 | Sep 1, 2022 |
| 4 | FORM 4 | 0001567619-22-017099 | Sep 6, 2022 | Sep 1, 2022 |
| 4 | FORM 4 | 0001567619-22-017098 | Sep 6, 2022 | Sep 1, 2022 |
| EFFECT | — | 9999999995-22-002599 | Sep 6, 2022 | — |
| CORRESP | — | 0001193125-22-236564 | Sep 1, 2022 | — |
| UPLOAD | — | 0000000000-22-009407 | Aug 30, 2022 | — |
| S-3 | S-3 | 0001193125-22-226652 | Aug 23, 2022 | — |
| 8-K | 8-K | 0000950170-22-016890 | Aug 11, 2022 | — |
| 10-Q | 10-Q | 0000950170-22-016882 | Aug 11, 2022 | Jun 30, 2022 |
| 3 | OWNERSHIP DOCUMENT | 0000921895-22-002106 | Jun 27, 2022 | Jun 16, 2022 |
| 4 | FORM 4 | 0001567619-22-013209 | Jun 21, 2022 | Jun 18, 2022 |
| SC 13G/A | AMENDMENT NO. 1 TO SCHEDULE 13G | 0000921895-22-002049 | Jun 21, 2022 | — |
| 8-K | 8-K | 0001193125-22-176718 | Jun 21, 2022 | Jun 14, 2022 |
| 8-K | 8-K | 0001193125-22-162490 | May 27, 2022 | May 23, 2022 |